The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hornung, V.
Right arrow Articles by Hartmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hornung, V.
Right arrow Articles by Hartmann, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 168: 4531-4537.
Copyright © 2002 by The American Association of Immunologists

Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1

Veit Hornung2,*, Simon Rothenfusser2,*, Stefanie Britsch*, Anne Krug*, Bernd Jahrsdörfer*, Thomas Giese{dagger}, Stefan Endres* and Gunther Hartmann3,*

* Department of Internal Medicine, Division of Clinical Pharmacology, University of Munich, Munich, Germany; and {dagger} Institute of Immunology, University of Heidelberg, Heidelberg, Germany

The Toll-like receptor (TLR)9 is critical for the recognition of immunostimulatory CpG motifs but may cooperate with other TLRs. We analyzed TLR1–10 mRNA expression by using quantitative real-time PCR in highly purified subsets of human PBMC and determined the sensitivity of these subsets to CpG oligodeoxynucleotides (ODN). TLR1 and TLR6 were expressed in all cell types examined. TLR10 was highly expressed in B cells and weakly expressed in plasmacytoid dendritic cells (PDC). High expression of TLR2 was characteristic for monocytes. PDC and B cells expressed marked levels of TLR7 and TLR9 and were directly sensitive to CpG ODN. In CpG ODN-stimulated PDC and B cells, TLR9 expression rapidly decreased, as opposed to TLR7, which was up-regulated in PDC and decreased in B cells. In monocytes, NK cells, and T cells, TLR7 was absent. Despite low expression of TLR9, monocytes, NK cells, and T cells did not respond to CpG ODN in the absence of PDC but were activated in the presence of PDC. In conclusion, our studies provide evidence that PDC and B cells, but not monocytes, NK cells, or T cells, are primary targets of CpG ODN in peripheral blood. The characteristic expression pattern of TLR1–10 in cellular subsets of human PBMC is consistent with the concept that TLR9 is essential in the recognition of CpG ODN in PDC and B cells. In addition, selective regulation of TLR7 expression in PDC and B cells by CpG ODN revealed TLR7 as a candidate TLR potentially involved in modulating the recognition of CpG motifs.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Bourquin, L. Schmidt, A.-L. Lanz, B. Storch, C. Wurzenberger, D. Anz, N. Sandholzer, R. Mocikat, M. Berger, H. Poeck, et al.
Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7
J. Immunol., November 15, 2009; 183(10): 6078 - 6086.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lartigue, N. Colliou, S. Calbo, A. Francois, S. Jacquot, C. Arnoult, F. Tron, D. Gilbert, and P. Musette
Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus
J. Immunol., November 15, 2009; 183(10): 6207 - 6216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Petzke, A. Brooks, M. A. Krupna, D. Mordue, and I. Schwartz
Recognition of Borrelia burgdorferi, the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells
J. Immunol., October 15, 2009; 183(8): 5279 - 5292.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Ganguly, G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, and M. Gilliet
Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
J. Exp. Med., August 31, 2009; 206(9): 1983 - 1994.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Gaudreault and J. Gosselin
Leukotriene B4 Potentiates CpG Signaling for Enhanced Cytokine Secretion by Human Leukocytes
J. Immunol., August 15, 2009; 183(4): 2650 - 2658.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. V. Pahl, S. Gollapudi, L. Sepassi, P. Gollapudi, R. Elahimehr, and N. D. Vaziri
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
Nephrol. Dial. Transplant., August 14, 2009; (2009) gfp397v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora
IFN-{alpha} amplifies human naive B cell TLR-9-mediated activation and Ig production
J. Leukoc. Biol., August 1, 2009; 86(2): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. C. Lindner, U. Kohl, T. J. Maier, D. Steinhilber, and B. L. Sorg
TLR2 ligands augment cPLA2{alpha} activity and lead to enhanced leukotriene release in human monocytes
J. Leukoc. Biol., August 1, 2009; 86(2): 389 - 399.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
A. Goodchild, N. Nopper, A. Craddock, T. Law, A. King, G. Fanning, L. Rivory, and T. Passioura
Primary Leukocyte Screens for Innate Immune Agonists
J Biomol Screen, July 1, 2009; 14(6): 723 - 730.
[Abstract] [PDF]


Home page
J. Immunol.Home page
A. F. de Vos, J. M. Pater, P. S. van den Pangaart, M. D. de Kruif, C. van 't Veer, and T. van der Poll
In Vivo Lipopolysaccharide Exposure of Human Blood Leukocytes Induces Cross-Tolerance to Multiple TLR Ligands
J. Immunol., July 1, 2009; 183(1): 533 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Zhang, C. J. Cox, K. M. Alvarez, and M. W. Cunningham
Cutting Edge: Cardiac Myosin Activates Innate Immune Responses through TLRs
J. Immunol., July 1, 2009; 183(1): 27 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Liang, R. S. Russell, N. L. Yonkers, D. McDonald, B. Rodriguez, C. V. Harding, and D. D. Anthony
Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells
J. Virol., June 1, 2009; 83(11): 5693 - 5707.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ablasser, H. Poeck, D. Anz, M. Berger, M. Schlee, S. Kim, C. Bourquin, N. Goutagny, Z. Jiang, K. A. Fitzgerald, et al.
Selection of Molecular Structure and Delivery of RNA Oligonucleotides to Activate TLR7 versus TLR8 and to Induce High Amounts of IL-12p70 in Primary Human Monocytes
J. Immunol., June 1, 2009; 182(11): 6824 - 6833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Ungaro, M. Fukata, D. Hsu, Y. Hernandez, K. Breglio, A. Chen, R. Xu, J. Sotolongo, C. Espana, J. Zaias, et al.
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis
Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1167 - G1179.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Tluk, M. Jurk, A. Forsbach, R. Weeratna, U. Samulowitz, A. M. Krieg, S. Bauer, and J. Vollmer
Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses
Int. Immunol., May 1, 2009; 21(5): 607 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Miller, T. B. Thornley, T. Pearson, A. J. Kruger, M. Yamazaki, L. D. Shultz, R. M. Welsh, M. A. Brehm, A. A. Rossini, and D. L. Greiner
TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade
J. Immunol., May 1, 2009; 182(9): 5547 - 5559.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Jendholm, M. Morgelin, M. L. A. Perez Vidakovics, M. Carlsson, H. Leffler, L.-O. Cardell, and K. Riesbeck
Superantigen- and TLR-Dependent Activation of Tonsillar B Cells after Receptor-Mediated Endocytosis
J. Immunol., April 15, 2009; 182(8): 4713 - 4720.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Shin, Y. Zhang, M. Jagannathan, H. Hasturk, A. Kantarci, H. Liu, T. E. Van Dyke, L. M. Ganley-Leal, and B. S. Nikolajczyk
B cells from periodontal disease patients express surface Toll-like receptor 4
J. Leukoc. Biol., April 1, 2009; 85(4): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Lore
Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells
J. Immunol., February 15, 2009; 182(4): 1991 - 2001.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Good, D. T. Avery, and S. G. Tangye
Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells
J. Immunol., January 15, 2009; 182(2): 890 - 901.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. K. Pfaller and K.-K. Conzelmann
Measles Virus V Protein Is a Decoy Substrate for I{kappa}B Kinase {alpha} and Prevents Toll-Like Receptor 7/9-Mediated Interferon Induction
J. Virol., December 15, 2008; 82(24): 12365 - 12373.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. M. Grauer, J. W. Molling, E. Bennink, L. W. J. Toonen, R. P. M. Sutmuller, S. Nierkens, and G. J. Adema
TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
J. Immunol., November 15, 2008; 181(10): 6720 - 6729.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. Kapitein, M. O. Hoekstra, E. H. J. Nijhuis, D. J. Hijnen, H. G. M. Arets, J. L. L. Kimpen, and E. F. Knol
Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes
Eur. Respir. J., November 1, 2008; 32(5): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, M. J. Ehrhardt, C. J. Lees, A. Panoskaltsis-Mortari, A. M. Krieg, A. H. Sharpe, W. J. Murphy, J. S. Serody, H. Hemmi, S. Akira, et al.
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection
Blood, October 15, 2008; 112(8): 3508 - 3516.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Klinman, H. Shirota, D. Tross, T. Sato, and S. Klaschik
Synthetic oligonucleotides as modulators of inflammation
J. Leukoc. Biol., October 1, 2008; 84(4): 958 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Parcina, C. Wendt, F. Goetz, R. Zawatzky, U. Zahringer, K. Heeg, and I. Bekeredjian-Ding
Staphylococcus aureus-Induced Plasmacytoid Dendritic Cell Activation Is Based on an IgG-Mediated Memory Response
J. Immunol., September 15, 2008; 181(6): 3823 - 3833.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego
Toll-like receptors: lessons to learn from normal and malignant human B cells
Blood, September 15, 2008; 112(6): 2205 - 2213.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. Marcenaro, B. Ferranti, M. Falco, L. Moretta, and A. Moretta
Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC
Int. Immunol., September 1, 2008; 20(9): 1155 - 1167.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. P. Wang, G. N. Bowen, C. Padden, A. Cerny, R. W. Finberg, P. E. Newburger, and E. A. Kurt-Jones
Toll-like receptor-mediated activation of neutrophils by influenza A virus
Blood, September 1, 2008; 112(5): 2028 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Jiang, M. M. Lederman, R. J. Mohner, B. Rodriguez, T. M. Nedrich, C. V. Harding, and S. F. Sieg
Impaired Naive and Memory B-Cell Responsiveness to TLR9 Stimulation in Human Immunodeficiency Virus Infection
J. Virol., August 15, 2008; 82(16): 7837 - 7845.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Shimizu, Y. Kida, and K. Kuwano
A Triacylated Lipoprotein from Mycoplasma genitalium Activates NF-{kappa}B through Toll-Like Receptor 1 (TLR1) and TLR2
Infect. Immun., August 1, 2008; 76(8): 3672 - 3678.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
E. L. J. M. Smits, P. Ponsaerts, Z. N. Berneman, and V. F. I. Van Tendeloo
The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
Oncologist, August 1, 2008; 13(8): 859 - 875.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Malaspina, S. Moir, A. C. DiPoto, J. Ho, W. Wang, G. Roby, M. A. O'Shea, and A. S. Fauci
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals
J. Immunol., July 15, 2008; 181(2): 1199 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. G. Molenkamp, B. J.R. Sluijter, P. A.M. van Leeuwen, S. J.A.M. Santegoets, S. Meijer, P. G.J.T.B. Wijnands, J. B.A.G. Haanen, A. J.M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
Clin. Cancer Res., July 15, 2008; 14(14): 4532 - 4542.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nierkens, M. H. den Brok, R. P.M. Sutmuller, O. M. Grauer, E. Bennink, M. E. Morgan, C. G. Figdor, T. J.M. Ruers, and G. J. Adema
In vivo Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer Immunotherapy
Cancer Res., July 1, 2008; 68(13): 5390 - 5396.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. N. Henning, A. K. Azad, K. V. L. Parsa, J. E. Crowther, S. Tridandapani, and L. S. Schlesinger
Pulmonary Surfactant Protein A Regulates TLR Expression and Activity in Human Macrophages
J. Immunol., June 15, 2008; 180(12): 7847 - 7858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Blohmke, R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. F. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al.
Innate Immunity Mediated by TLR5 as a Novel Antiinflammatory Target for Cystic Fibrosis Lung Disease
J. Immunol., June 1, 2008; 180(11): 7764 - 7773.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. Rosen, W. Cao, D. T. Avery, S. G. Tangye, Y.-J. Liu, J. P. Houchins, and L. L. Lanier
Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
J. Immunol., May 15, 2008; 180(10): 6508 - 6517.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Shen, K. Stone, A. Jales, D. Leitenberg, and S. Ladisch
Inhibition of TLR Activation and Up-Regulation of IL-1R-Associated Kinase-M Expression by Exogenous Gangliosides
J. Immunol., April 1, 2008; 180(7): 4425 - 4432.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. K. Juckem, K. W. Boehme, A. L. Feire, and T. Compton
Differential Initiation of Innate Immune Responses Induced by Human Cytomegalovirus Entry into Fibroblast Cells
J. Immunol., April 1, 2008; 180(7): 4965 - 4977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Forsbach, J.-G. Nemorin, C. Montino, C. Muller, U. Samulowitz, A. P. Vicari, M. Jurk, G. K. Mutwiri, A. M. Krieg, G. B. Lipford, et al.
Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
J. Immunol., March 15, 2008; 180(6): 3729 - 3738.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Athie-Morales, G. M. O'Connor, and C. M. Gardiner
Activation of Human NK Cells by the Bacterial Pathogen-Associated Molecular Pattern Muramyl Dipeptide
J. Immunol., March 15, 2008; 180(6): 4082 - 4089.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
F.-x. Wang, J. Huang, H. Zhang, X. Ma, and H. Zhang
APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells
J. Gen. Virol., March 1, 2008; 89(3): 722 - 730.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. P. Gantier, S. Tong, M. A. Behlke, D. Xu, S. Phipps, P. S. Foster, and B. R. G. Williams
TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
J. Immunol., February 15, 2008; 180(4): 2117 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Ukai, H. Yumoto, F. C. Gibson III, and C. A. Genco
Macrophage-Elicited Osteoclastogenesis in Response to Bacterial Stimulation Requires Toll-Like Receptor 2-Dependent Tumor Necrosis Factor-Alpha Production
Infect. Immun., February 1, 2008; 76(2): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Veckman and I. Julkunen
Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells
J. Leukoc. Biol., February 1, 2008; 83(2): 296 - 304.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Fukata, K. Breglio, A. Chen, A. S. Vamadevan, T. Goo, D. Hsu, D. Conduah, R. Xu, and M. T. Abreu
The Myeloid Differentiation Factor 88 (MyD88) Is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel Disease
J. Immunol., February 1, 2008; 180(3): 1886 - 1894.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Capolunghi, S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al.
CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies
J. Immunol., January 15, 2008; 180(2): 800 - 808.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Shimizu, Y. Kida, and K. Kuwano
Mycoplasma pneumoniae-Derived Lipopeptides Induce Acute Inflammatory Responses in the Lungs of Mice
Infect. Immun., January 1, 2008; 76(1): 270 - 277.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. K. Reeves and P. N. Fultz
Characterization of Plasmacytoid Dendritic Cells in Bone Marrow of Pig-Tailed Macaques
Clin. Vaccine Immunol., January 1, 2008; 15(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Z. Dudek, C. Yunis, L. I. Harrison, S. Kumar, R. Hawkinson, S. Cooley, J. P. Vasilakos, K. S. Gorski, and J. S. Miller
First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7119 - 7125.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Funderburg, M. M. Lederman, Z. Feng, M. G. Drage, J. Jadlowsky, C. V. Harding, A. Weinberg, and S. F. Sieg
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2
PNAS, November 20, 2007; 104(47): 18631 - 18635.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Ishikawa, H. Niiro, T. Iino, S. Yoshida, N. Saito, S. Onohara, T. Miyamoto, H. Minagawa, S.-i. Fujii, L. D. Shultz, et al.
The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways
Blood, November 15, 2007; 110(10): 3591 - 3660.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. P. Leonard, B. K. Link, C. Emmanouilides, S. A. Gregory, D. Weisdorf, J. Andrey, J. Hainsworth, J. A. Sparano, D. E. Tsai, S. Horning, et al.
Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non Hodgkin's Lymphoma
Clin. Cancer Res., October 15, 2007; 13(20): 6168 - 6174.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Chen, E. Giovannucci, P. Kraft, R. Lazarus, and D. J. Hunter
Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1982 - 1989.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Thibault, M. R. Tardif, C. Barat, and M. J. Tremblay
TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1
J. Immunol., October 1, 2007; 179(7): 4357 - 4366.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Martin, J. M. Lee, D. Walls, and S. D. Hayward
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
J. Virol., September 15, 2007; 81(18): 9748 - 9758.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Alter, T. J. Suscovich, N. Teigen, A. Meier, H. Streeck, C. Brander, and M. Altfeld
Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells
J. Immunol., June 15, 2007; 178(12): 7658 - 7666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Batra, J. Pietsch, I. Fedke, R. Glauben, B. Okur, T. Stroh, M. Zeitz, and B. Siegmund
Leptin-Dependent Toll-Like Receptor Expression and Responsiveness in Preadipocytes and Adipocytes
Am. J. Pathol., June 1, 2007; 170(6): 1931 - 1941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Severa, M. E. Remoli, E. Giacomini, V. Annibali, V. Gafa, R. Lande, M. Tomai, M. Salvetti, and E. M. Coccia
Sensitization to TLR7 Agonist in IFN-beta-Preactivated Dendritic Cells
J. Immunol., May 15, 2007; 178(10): 6208 - 6216.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, B. J.R. Sluijter, P. G.J.T.B. Wijnands, A. Baars, A. J.M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients
Clin. Cancer Res., May 15, 2007; 13(10): 2961 - 2969.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al.
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
J. Exp. Med., April 16, 2007; 204(4): 893 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. C. Gray, J. Kuchtey, and C. V. Harding
CpG-B ODNs potently induce low levels of IFN-{alpha}{beta} and induce IFN-{alpha}{beta}-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs
J. Leukoc. Biol., April 1, 2007; 81(4): 1075 - 1085.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Berghofer, G. Haley, T. Frommer, G. Bein, and H. Hackstein
Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-{alpha} Production
J. Immunol., April 1, 2007; 178(7): 4072 - 4079.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Bourquin, L. Schmidt, V. Hornung, C. Wurzenberger, D. Anz, N. Sandholzer, S. Schreiber, A. Voelkl, G. Hartmann, and S. Endres
Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response
Blood, April 1, 2007; 109(7): 2953 - 2960.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. M. Kraft, F. Krux, S. Schimmer, C. Ohlen, P. D. Greenberg, and U. Dittmer
CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection
Blood, April 1, 2007; 109(7): 2982 - 2984.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Wang, D. R. Asher, M. Chan, E. A. Kurt-Jones, and R. W. Finberg
Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA
J. Immunol., March 15, 2007; 178(6): 3363 - 3367.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Hamm, A. Heit, M. Koffler, K. M. Huster, S. Akira, D. H. Busch, H. Wagner, and S. Bauer
Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo
Int. Immunol., March 1, 2007; 19(3): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways
Int. Immunol., March 1, 2007; 19(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Bekeredjian-Ding, S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zahringer, and G. Hartmann
Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands
J. Immunol., March 1, 2007; 178(5): 2803 - 2812.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Mayer, M. Muehmer, J. Mages, K. Gueinzius, C. Hess, K. Heeg, R. Bals, R. Lang, and A. H. Dalpke
Differential Recognition of TLR-Dependent Microbial Ligands in Human Bronchial Epithelial Cells
J. Immunol., March 1, 2007; 178(5): 3134 - 3142.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Winkler, D. Ghadimi, J. Schrezenmeir, and J.-P. Kraehenbuhl
Molecular and Cellular Basis of Microflora-Host Interactions
J. Nutr., March 1, 2007; 137(3): 756S - 772S.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Osterloh, U. Kalinke, S. Weiss, B. Fleischer, and M. Breloer
Synergistic and Differential Modulation of Immune Responses by Hsp60 and Lipopolysaccharide
J. Biol. Chem., February 16, 2007; 282(7): 4669 - 4680.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M.G. van der Aar, R. M. R. Sylva-Steenland, J. D. Bos, M. L. Kapsenberg, E. C. de Jong, and M. B. M. Teunissen
Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition
J. Immunol., February 15, 2007; 178(4): 1986 - 1990.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Zhou, H. Wei, and Z. Tian
NK3-Like NK Cells Are Involved in Protective Effect of Polyinosinic-Polycytidylic Acid on Type 1 Diabetes in Nonobese Diabetic Mice
J. Immunol., February 15, 2007; 178(4): 2141 - 2147.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Huggins, T. Pellegrin, R. E. Felgar, C. Wei, M. Brown, B. Zheng, E. C. B. Milner, S. H. Bernstein, I. Sanz, and M. S. Zand
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells
Blood, February 15, 2007; 109(4): 1611 - 1619.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Zipris, E. Lien, A. Nair, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini
TLR9-Signaling Pathways Are Involved in Kilham Rat Virus-Induced Autoimmune Diabetes in the Biobreeding Diabetes-Resistant Rat
J. Immunol., January 15, 2007; 178(2): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Pashenkov, G. Goess, C. Wagner, M. Hormann, T. Jandl, A. Moser, C. M. Britten, J. Smolle, S. Koller, C. Mauch, et al.
Phase II Trial of a Toll-Like Receptor 9-Activating Oligonucleotide in Patients With Metastatic Melanoma
J. Clin. Oncol., December 20, 2006; 24(36): 5716 - 5724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Popovic, R. DeMarco, M. T. Lotze, S. E. Winikoff, D. L. Bartlett, A. M. Krieg, Z. S. Guo, C. K. Brown, K. J. Tracey, and H. J. Zeh III
High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists
J. Immunol., December 15, 2006; 177(12): 8701 - 8707.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Tabiasco, E. Devevre, N. Rufer, B. Salaun, J.-C. Cerottini, D. Speiser, and P. Romero
Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor
J. Immunol., December 15, 2006; 177(12): 8708 - 8713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Bartz, N. M. Avalos, A. Baetz, K. Heeg, and A. H. Dalpke
Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation
Blood, December 15, 2006; 108(13): 4102 - 4108.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, Y. Shao, T. A. Bennett, R. A. Shankar, P. D. Wightman, and L. G. Reddy
The Functional Effects of Physical Interactions among Toll-like Receptors 7, 8, and 9
J. Biol. Chem., December 8, 2006; 281(49): 37427 - 37434.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. A. Shirey, J.-Y. Jung, and J. M. Carlin
Up-Regulation of Gamma Interferon Receptor Expression Due to Chlamydia-Toll-Like Receptor Interaction Does Not Enhance Signal Transducer and Activator of Transcription 1 Signaling
Infect. Immun., December 1, 2006; 74(12): 6877 - 6884.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Hoene, M. Peiser, and R. Wanner
Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19
J. Leukoc. Biol., December 1, 2006; 80(6): 1328 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Paladino, D. T. Cummings, R. S. Noyce, and K. L. Mossman
The IFN-Independent Response to Virus Particle Entry Provides a First Line of Antiviral Defense That Is Independent of TLRs and Retinoic Acid-Inducible Gene I
J. Immunol., December 1, 2006; 177(11): 8008 - 8016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. K. B. Gorden, X. Qiu, J. J. L. Battiste, P. P. D. Wightman, J. P. Vasilakos, and S. S. Alkan
Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines
J. Immunol., December 1, 2006; 177(11): 8164 - 8170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Dolganiuc, S. Chang, K. Kodys, P. Mandrekar, G. Bakis, M. Cormier, and G. Szabo
Hepatitis C Virus (HCV) Core Protein-Induced, Monocyte-Mediated Mechanisms of Reduced IFN-{alpha} and Plasmacytoid Dendritic Cell Loss in Chronic HCV Infection
J. Immunol., November 15, 2006; 177(10): 6758 - 6768.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. S. Patole, R. D. Pawar, M. Lech, D. Zecher, H. Schmidt, S. Segerer, A. Ellwart, A. Henger, M. Kretzler, and H.-J. Anders
Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3062 - 3073.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
E. Hartmann, H. Graefe, A. Hopert, R. Pries, S. Rothenfusser, H. Poeck, B. Mack, S. Endres, G. Hartmann, and B. Wollenberg
Analysis of Plasmacytoid and Myeloid Dendritic Cells in Nasal Epithelium
Clin. Vaccine Immunol., November 1, 2006; 13(11): 1278 - 1286.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.